GlaxoSmithKline Holdings (Americas) Inc. v. Commissioner of the IRS

Analysis Group, retained by McKee Nelson LLP, assisted GlaxoSmithKline (GSK) in its long-running transfer pricing dispute with the Internal Revenue Service. The dispute concerned how much of the profits from the U.S. sale of certain GSK drugs should be attributed to U.S. subsidiaries of GSK and thus subject to U.S. tax.

Analysis Group supported academics (including MIT Professors Robert Pindyck and Ernst Berndt and University of Florida Professor Christopher James) and others who provided expertise in econometrics, pharmaceutical marketing, stock price analysis, licensing practices, and historic mergers and acquisitions in the pharmaceutical industry.

The Analysis Group team included President Pierre Cremieux, Managing Principals Laurits ChristensenMaureen Chakraborty, Rebecca Kirk Fair, and Alan White, and Vice Presidents David Mishol and Tamar Sisitsky. This team also supported experts addressing licensing and contracting procedures in the pharmaceutical industry and the environment for mergers and acquisitions among pharmaceutical companies in the U.S. during the 1980s.